Genmab A/S banner

Genmab A/S
OTC:GNMSF

Watchlist Manager
Genmab A/S Logo
Genmab A/S
OTC:GNMSF
Watchlist
Price: 249.45 USD
Market Cap: $16.3B

Wall St Price Targets

GNMSF Price Targets Summary
Genmab A/S

Wall Street analysts forecast GNMSF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNMSF is 358.36 USD with a low forecast of 206.84 USD and a high forecast of 496.22 USD.

Lowest Forecast
Price Target
206.84 USD
17% Downside
Average Forecast
Price Target
358.36 USD
44% Upside
Highest Forecast
Price Target
496.22 USD
99% Upside
Genmab A/S Competitors:
Price Targets
ORLY
O'Reilly Automotive Inc
24% Upside
BRI
Britania PCL
11% Upside

Revenue
Forecast

34% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
34% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Genmab A/S

Operating Income
Forecast

N/A
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 10%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Genmab A/S

Net Income
Forecast

N/A
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat

The compound annual growth rate for Net Income over the next 8 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GNMSF's stock price target?
Price Target
358.36 USD

According to Wall Street analysts, the average 1-year price target for GNMSF is 358.36 USD with a low forecast of 206.84 USD and a high forecast of 496.22 USD.

What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%

The compound annual growth rate for Operating Income over the next 8 years is 10%.

What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%

The compound annual growth rate for Net Income over the next 8 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett